开云app官网登录入口网页版-官方正版

[GetPortalCommentsPageByObjectIdResponse(id=2225400, encodeId=3ef5222540019, content=偏重的研究方向：肿瘤免疫 经验分享：with editor已经一周了，还是没有变化，这是正常的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65865684646, createdName=ms9000000770995662, createdTime=Thu Sep 12 15:26:21 CST 2024, time=2024-09-12, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2198977, encodeId=638821989e77f, content=做肿瘤免疫。有相关的六七八分的杂志推荐吗，跪求着急毕业, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d0fe8528077, createdName=ms5000000719501821, createdTime=Wed Apr 17 17:11:02 CST 2024, time=2024-04-17, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2222833, encodeId=3b492222833b4, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d1d1660995, createdName=1ddebd51m79(暂无匿称), createdTime=Wed Aug 28 14:24:59 CST 2024, time=2024-08-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2222682, encodeId=8d15222268246, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d1d1660995, createdName=1ddebd51m79(暂无匿称), createdTime=Tue Aug 27 16:09:37 CST 2024, time=2024-08-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2105348, encodeId=7306210534879, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤免疫 经验分享：写了一篇研究性质的letter,1000字左右，投稿后两天直接接收，只能用两个字形容：效率！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520f5425099, createdName=ms3000001872426513, createdTime=Sun Dec 11 11:52:23 CST 2022, time=2022-12-11, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=1057958, encodeId=9aa8105e9580b, content=9-23 submittted 9-26 with editor 9-29 decision in process 10-5 reject 和很多人说的一样，decision in process状态持续的很久。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d21b5560214, createdName=YJJJJJ, createdTime=Tue Oct 05 21:45:10 CST 2021, time=2021-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202427, encodeId=d830120242e02, content=偏重的研究方向：肿瘤 经验分享：写了一篇letter，一个月还在with editor，啥情况啊？有人知道不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0f72309028, createdName=122220a4m01暂无昵称, createdTime=Mon Mar 14 11:29:30 CST 2022, time=2022-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2193317, encodeId=51d0219331ead, content=偏重的研究方向：肿瘤 经验分享：2.27投稿，3.15拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=109a8327611, createdName=ms6000000136446040, createdTime=Fri Mar 15 09:16:46 CST 2024, time=2024-03-15, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2181884, encodeId=af9721818848a, content=偏重的研究方向：肿瘤;肿瘤免疫 经验分享：with editor 2周，进入decsion in process流程，是要凉凉了吗请问?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f7d6548351, createdName=ms6000001244498457, createdTime=Mon Jan 15 21:53:20 CST 2024, time=2024-01-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2189742, encodeId=2fb32189e4282, content=投稿第二天with editor，目前 8天了状态仍然没有变化, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85799188946, createdName=ms1000001401340130, createdTime=Tue Feb 27 20:34:26 CST 2024, time=2024-02-27, status=1, ipAttribution=湖北省)]

2024-09-12 ms9000000770995662 来自天津

偏重的研究方向：肿瘤免疫
经验分享：with editor已经一周了，还是没有变化，这是正常的吗？

4 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2225400, encodeId=3ef5222540019, content=偏重的研究方向：肿瘤免疫 经验分享：with editor已经一周了，还是没有变化，这是正常的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65865684646, createdName=ms9000000770995662, createdTime=Thu Sep 12 15:26:21 CST 2024, time=2024-09-12, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2198977, encodeId=638821989e77f, content=做肿瘤免疫。有相关的六七八分的杂志推荐吗，跪求着急毕业, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d0fe8528077, createdName=ms5000000719501821, createdTime=Wed Apr 17 17:11:02 CST 2024, time=2024-04-17, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2222833, encodeId=3b492222833b4, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d1d1660995, createdName=1ddebd51m79(暂无匿称), createdTime=Wed Aug 28 14:24:59 CST 2024, time=2024-08-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2222682, encodeId=8d15222268246, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d1d1660995, createdName=1ddebd51m79(暂无匿称), createdTime=Tue Aug 27 16:09:37 CST 2024, time=2024-08-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2105348, encodeId=7306210534879, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤免疫 经验分享：写了一篇研究性质的letter,1000字左右，投稿后两天直接接收，只能用两个字形容：效率！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520f5425099, createdName=ms3000001872426513, createdTime=Sun Dec 11 11:52:23 CST 2022, time=2022-12-11, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=1057958, encodeId=9aa8105e9580b, content=9-23 submittted 9-26 with editor 9-29 decision in process 10-5 reject 和很多人说的一样，decision in process状态持续的很久。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d21b5560214, createdName=YJJJJJ, createdTime=Tue Oct 05 21:45:10 CST 2021, time=2021-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202427, encodeId=d830120242e02, content=偏重的研究方向：肿瘤 经验分享：写了一篇letter，一个月还在with editor，啥情况啊？有人知道不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0f72309028, createdName=122220a4m01暂无昵称, createdTime=Mon Mar 14 11:29:30 CST 2022, time=2022-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2193317, encodeId=51d0219331ead, content=偏重的研究方向：肿瘤 经验分享：2.27投稿，3.15拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=109a8327611, createdName=ms6000000136446040, createdTime=Fri Mar 15 09:16:46 CST 2024, time=2024-03-15, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2181884, encodeId=af9721818848a, content=偏重的研究方向：肿瘤;肿瘤免疫 经验分享：with editor 2周，进入decsion in process流程，是要凉凉了吗请问?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f7d6548351, createdName=ms6000001244498457, createdTime=Mon Jan 15 21:53:20 CST 2024, time=2024-01-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2189742, encodeId=2fb32189e4282, content=投稿第二天with editor，目前 8天了状态仍然没有变化, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85799188946, createdName=ms1000001401340130, createdTime=Tue Feb 27 20:34:26 CST 2024, time=2024-02-27, status=1, ipAttribution=湖北省)]

2024-04-17 ms5000000719501821 来自上海

做肿瘤免疫。有相关的六七八分的杂志推荐吗，跪求着急毕业

59 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2225400, encodeId=3ef5222540019, content=偏重的研究方向：肿瘤免疫 经验分享：with editor已经一周了，还是没有变化，这是正常的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65865684646, createdName=ms9000000770995662, createdTime=Thu Sep 12 15:26:21 CST 2024, time=2024-09-12, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2198977, encodeId=638821989e77f, content=做肿瘤免疫。有相关的六七八分的杂志推荐吗，跪求着急毕业, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d0fe8528077, createdName=ms5000000719501821, createdTime=Wed Apr 17 17:11:02 CST 2024, time=2024-04-17, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2222833, encodeId=3b492222833b4, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d1d1660995, createdName=1ddebd51m79(暂无匿称), createdTime=Wed Aug 28 14:24:59 CST 2024, time=2024-08-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2222682, encodeId=8d15222268246, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d1d1660995, createdName=1ddebd51m79(暂无匿称), createdTime=Tue Aug 27 16:09:37 CST 2024, time=2024-08-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2105348, encodeId=7306210534879, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤免疫 经验分享：写了一篇研究性质的letter,1000字左右，投稿后两天直接接收，只能用两个字形容：效率！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520f5425099, createdName=ms3000001872426513, createdTime=Sun Dec 11 11:52:23 CST 2022, time=2022-12-11, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=1057958, encodeId=9aa8105e9580b, content=9-23 submittted 9-26 with editor 9-29 decision in process 10-5 reject 和很多人说的一样，decision in process状态持续的很久。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d21b5560214, createdName=YJJJJJ, createdTime=Tue Oct 05 21:45:10 CST 2021, time=2021-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202427, encodeId=d830120242e02, content=偏重的研究方向：肿瘤 经验分享：写了一篇letter，一个月还在with editor，啥情况啊？有人知道不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0f72309028, createdName=122220a4m01暂无昵称, createdTime=Mon Mar 14 11:29:30 CST 2022, time=2022-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2193317, encodeId=51d0219331ead, content=偏重的研究方向：肿瘤 经验分享：2.27投稿，3.15拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=109a8327611, createdName=ms6000000136446040, createdTime=Fri Mar 15 09:16:46 CST 2024, time=2024-03-15, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2181884, encodeId=af9721818848a, content=偏重的研究方向：肿瘤;肿瘤免疫 经验分享：with editor 2周，进入decsion in process流程，是要凉凉了吗请问?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f7d6548351, createdName=ms6000001244498457, createdTime=Mon Jan 15 21:53:20 CST 2024, time=2024-01-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2189742, encodeId=2fb32189e4282, content=投稿第二天with editor，目前 8天了状态仍然没有变化, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85799188946, createdName=ms1000001401340130, createdTime=Tue Feb 27 20:34:26 CST 2024, time=2024-02-27, status=1, ipAttribution=湖北省)]

2024-08-28 1ddebd51m79(暂无匿称) 来自浙江省

无

22 0

[GetPortalCommentsPageByObjectIdResponse(id=2225400, encodeId=3ef5222540019, content=偏重的研究方向：肿瘤免疫 经验分享：with editor已经一周了，还是没有变化，这是正常的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65865684646, createdName=ms9000000770995662, createdTime=Thu Sep 12 15:26:21 CST 2024, time=2024-09-12, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2198977, encodeId=638821989e77f, content=做肿瘤免疫。有相关的六七八分的杂志推荐吗，跪求着急毕业, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d0fe8528077, createdName=ms5000000719501821, createdTime=Wed Apr 17 17:11:02 CST 2024, time=2024-04-17, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2222833, encodeId=3b492222833b4, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d1d1660995, createdName=1ddebd51m79(暂无匿称), createdTime=Wed Aug 28 14:24:59 CST 2024, time=2024-08-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2222682, encodeId=8d15222268246, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d1d1660995, createdName=1ddebd51m79(暂无匿称), createdTime=Tue Aug 27 16:09:37 CST 2024, time=2024-08-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2105348, encodeId=7306210534879, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤免疫 经验分享：写了一篇研究性质的letter,1000字左右，投稿后两天直接接收，只能用两个字形容：效率！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520f5425099, createdName=ms3000001872426513, createdTime=Sun Dec 11 11:52:23 CST 2022, time=2022-12-11, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=1057958, encodeId=9aa8105e9580b, content=9-23 submittted 9-26 with editor 9-29 decision in process 10-5 reject 和很多人说的一样，decision in process状态持续的很久。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d21b5560214, createdName=YJJJJJ, createdTime=Tue Oct 05 21:45:10 CST 2021, time=2021-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202427, encodeId=d830120242e02, content=偏重的研究方向：肿瘤 经验分享：写了一篇letter，一个月还在with editor，啥情况啊？有人知道不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0f72309028, createdName=122220a4m01暂无昵称, createdTime=Mon Mar 14 11:29:30 CST 2022, time=2022-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2193317, encodeId=51d0219331ead, content=偏重的研究方向：肿瘤 经验分享：2.27投稿，3.15拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=109a8327611, createdName=ms6000000136446040, createdTime=Fri Mar 15 09:16:46 CST 2024, time=2024-03-15, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2181884, encodeId=af9721818848a, content=偏重的研究方向：肿瘤;肿瘤免疫 经验分享：with editor 2周，进入decsion in process流程，是要凉凉了吗请问?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f7d6548351, createdName=ms6000001244498457, createdTime=Mon Jan 15 21:53:20 CST 2024, time=2024-01-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2189742, encodeId=2fb32189e4282, content=投稿第二天with editor，目前 8天了状态仍然没有变化, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85799188946, createdName=ms1000001401340130, createdTime=Tue Feb 27 20:34:26 CST 2024, time=2024-02-27, status=1, ipAttribution=湖北省)]

2024-08-27 1ddebd51m79(暂无匿称) 来自浙江省

无

27 0

[GetPortalCommentsPageByObjectIdResponse(id=2225400, encodeId=3ef5222540019, content=偏重的研究方向：肿瘤免疫 经验分享：with editor已经一周了，还是没有变化，这是正常的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65865684646, createdName=ms9000000770995662, createdTime=Thu Sep 12 15:26:21 CST 2024, time=2024-09-12, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2198977, encodeId=638821989e77f, content=做肿瘤免疫。有相关的六七八分的杂志推荐吗，跪求着急毕业, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d0fe8528077, createdName=ms5000000719501821, createdTime=Wed Apr 17 17:11:02 CST 2024, time=2024-04-17, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2222833, encodeId=3b492222833b4, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d1d1660995, createdName=1ddebd51m79(暂无匿称), createdTime=Wed Aug 28 14:24:59 CST 2024, time=2024-08-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2222682, encodeId=8d15222268246, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d1d1660995, createdName=1ddebd51m79(暂无匿称), createdTime=Tue Aug 27 16:09:37 CST 2024, time=2024-08-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2105348, encodeId=7306210534879, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤免疫 经验分享：写了一篇研究性质的letter,1000字左右，投稿后两天直接接收，只能用两个字形容：效率！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520f5425099, createdName=ms3000001872426513, createdTime=Sun Dec 11 11:52:23 CST 2022, time=2022-12-11, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=1057958, encodeId=9aa8105e9580b, content=9-23 submittted 9-26 with editor 9-29 decision in process 10-5 reject 和很多人说的一样，decision in process状态持续的很久。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d21b5560214, createdName=YJJJJJ, createdTime=Tue Oct 05 21:45:10 CST 2021, time=2021-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202427, encodeId=d830120242e02, content=偏重的研究方向：肿瘤 经验分享：写了一篇letter，一个月还在with editor，啥情况啊？有人知道不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0f72309028, createdName=122220a4m01暂无昵称, createdTime=Mon Mar 14 11:29:30 CST 2022, time=2022-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2193317, encodeId=51d0219331ead, content=偏重的研究方向：肿瘤 经验分享：2.27投稿，3.15拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=109a8327611, createdName=ms6000000136446040, createdTime=Fri Mar 15 09:16:46 CST 2024, time=2024-03-15, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2181884, encodeId=af9721818848a, content=偏重的研究方向：肿瘤;肿瘤免疫 经验分享：with editor 2周，进入decsion in process流程，是要凉凉了吗请问?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f7d6548351, createdName=ms6000001244498457, createdTime=Mon Jan 15 21:53:20 CST 2024, time=2024-01-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2189742, encodeId=2fb32189e4282, content=投稿第二天with editor，目前 8天了状态仍然没有变化, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85799188946, createdName=ms1000001401340130, createdTime=Tue Feb 27 20:34:26 CST 2024, time=2024-02-27, status=1, ipAttribution=湖北省)]

2022-12-11 ms3000001872426513 来自河南省

审稿速度:1.0 | 投稿命中率:50.0
偏重的研究方向：肿瘤免疫
经验分享：写了一篇研究性质的letter,1000字左右，投稿后两天直接接收，只能用两个字形容：效率！

3 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2225400, encodeId=3ef5222540019, content=偏重的研究方向：肿瘤免疫 经验分享：with editor已经一周了，还是没有变化，这是正常的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65865684646, createdName=ms9000000770995662, createdTime=Thu Sep 12 15:26:21 CST 2024, time=2024-09-12, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2198977, encodeId=638821989e77f, content=做肿瘤免疫。有相关的六七八分的杂志推荐吗，跪求着急毕业, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d0fe8528077, createdName=ms5000000719501821, createdTime=Wed Apr 17 17:11:02 CST 2024, time=2024-04-17, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2222833, encodeId=3b492222833b4, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d1d1660995, createdName=1ddebd51m79(暂无匿称), createdTime=Wed Aug 28 14:24:59 CST 2024, time=2024-08-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2222682, encodeId=8d15222268246, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d1d1660995, createdName=1ddebd51m79(暂无匿称), createdTime=Tue Aug 27 16:09:37 CST 2024, time=2024-08-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2105348, encodeId=7306210534879, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤免疫 经验分享：写了一篇研究性质的letter,1000字左右，投稿后两天直接接收，只能用两个字形容：效率！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520f5425099, createdName=ms3000001872426513, createdTime=Sun Dec 11 11:52:23 CST 2022, time=2022-12-11, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=1057958, encodeId=9aa8105e9580b, content=9-23 submittted 9-26 with editor 9-29 decision in process 10-5 reject 和很多人说的一样，decision in process状态持续的很久。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d21b5560214, createdName=YJJJJJ, createdTime=Tue Oct 05 21:45:10 CST 2021, time=2021-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202427, encodeId=d830120242e02, content=偏重的研究方向：肿瘤 经验分享：写了一篇letter，一个月还在with editor，啥情况啊？有人知道不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0f72309028, createdName=122220a4m01暂无昵称, createdTime=Mon Mar 14 11:29:30 CST 2022, time=2022-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2193317, encodeId=51d0219331ead, content=偏重的研究方向：肿瘤 经验分享：2.27投稿，3.15拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=109a8327611, createdName=ms6000000136446040, createdTime=Fri Mar 15 09:16:46 CST 2024, time=2024-03-15, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2181884, encodeId=af9721818848a, content=偏重的研究方向：肿瘤;肿瘤免疫 经验分享：with editor 2周，进入decsion in process流程，是要凉凉了吗请问?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f7d6548351, createdName=ms6000001244498457, createdTime=Mon Jan 15 21:53:20 CST 2024, time=2024-01-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2189742, encodeId=2fb32189e4282, content=投稿第二天with editor，目前 8天了状态仍然没有变化, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85799188946, createdName=ms1000001401340130, createdTime=Tue Feb 27 20:34:26 CST 2024, time=2024-02-27, status=1, ipAttribution=湖北省)]

2021-10-05 YJJJJJ

9-23 submittted
9-26 with editor
9-29 decision in process
10-5 reject
和很多人说的一样，decision in process状态持续的很久。

130 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2225400, encodeId=3ef5222540019, content=偏重的研究方向：肿瘤免疫 经验分享：with editor已经一周了，还是没有变化，这是正常的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65865684646, createdName=ms9000000770995662, createdTime=Thu Sep 12 15:26:21 CST 2024, time=2024-09-12, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2198977, encodeId=638821989e77f, content=做肿瘤免疫。有相关的六七八分的杂志推荐吗，跪求着急毕业, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d0fe8528077, createdName=ms5000000719501821, createdTime=Wed Apr 17 17:11:02 CST 2024, time=2024-04-17, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2222833, encodeId=3b492222833b4, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d1d1660995, createdName=1ddebd51m79(暂无匿称), createdTime=Wed Aug 28 14:24:59 CST 2024, time=2024-08-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2222682, encodeId=8d15222268246, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d1d1660995, createdName=1ddebd51m79(暂无匿称), createdTime=Tue Aug 27 16:09:37 CST 2024, time=2024-08-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2105348, encodeId=7306210534879, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤免疫 经验分享：写了一篇研究性质的letter,1000字左右，投稿后两天直接接收，只能用两个字形容：效率！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520f5425099, createdName=ms3000001872426513, createdTime=Sun Dec 11 11:52:23 CST 2022, time=2022-12-11, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=1057958, encodeId=9aa8105e9580b, content=9-23 submittted 9-26 with editor 9-29 decision in process 10-5 reject 和很多人说的一样，decision in process状态持续的很久。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d21b5560214, createdName=YJJJJJ, createdTime=Tue Oct 05 21:45:10 CST 2021, time=2021-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202427, encodeId=d830120242e02, content=偏重的研究方向：肿瘤 经验分享：写了一篇letter，一个月还在with editor，啥情况啊？有人知道不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0f72309028, createdName=122220a4m01暂无昵称, createdTime=Mon Mar 14 11:29:30 CST 2022, time=2022-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2193317, encodeId=51d0219331ead, content=偏重的研究方向：肿瘤 经验分享：2.27投稿，3.15拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=109a8327611, createdName=ms6000000136446040, createdTime=Fri Mar 15 09:16:46 CST 2024, time=2024-03-15, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2181884, encodeId=af9721818848a, content=偏重的研究方向：肿瘤;肿瘤免疫 经验分享：with editor 2周，进入decsion in process流程，是要凉凉了吗请问?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f7d6548351, createdName=ms6000001244498457, createdTime=Mon Jan 15 21:53:20 CST 2024, time=2024-01-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2189742, encodeId=2fb32189e4282, content=投稿第二天with editor，目前 8天了状态仍然没有变化, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85799188946, createdName=ms1000001401340130, createdTime=Tue Feb 27 20:34:26 CST 2024, time=2024-02-27, status=1, ipAttribution=湖北省)]

2022-03-14 122220a4m01暂无昵称

偏重的研究方向：肿瘤
经验分享：写了一篇letter，一个月还在with editor，啥情况啊？有人知道不？

118 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2225400, encodeId=3ef5222540019, content=偏重的研究方向：肿瘤免疫 经验分享：with editor已经一周了，还是没有变化，这是正常的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65865684646, createdName=ms9000000770995662, createdTime=Thu Sep 12 15:26:21 CST 2024, time=2024-09-12, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2198977, encodeId=638821989e77f, content=做肿瘤免疫。有相关的六七八分的杂志推荐吗，跪求着急毕业, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d0fe8528077, createdName=ms5000000719501821, createdTime=Wed Apr 17 17:11:02 CST 2024, time=2024-04-17, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2222833, encodeId=3b492222833b4, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d1d1660995, createdName=1ddebd51m79(暂无匿称), createdTime=Wed Aug 28 14:24:59 CST 2024, time=2024-08-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2222682, encodeId=8d15222268246, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d1d1660995, createdName=1ddebd51m79(暂无匿称), createdTime=Tue Aug 27 16:09:37 CST 2024, time=2024-08-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2105348, encodeId=7306210534879, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤免疫 经验分享：写了一篇研究性质的letter,1000字左右，投稿后两天直接接收，只能用两个字形容：效率！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520f5425099, createdName=ms3000001872426513, createdTime=Sun Dec 11 11:52:23 CST 2022, time=2022-12-11, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=1057958, encodeId=9aa8105e9580b, content=9-23 submittted 9-26 with editor 9-29 decision in process 10-5 reject 和很多人说的一样，decision in process状态持续的很久。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d21b5560214, createdName=YJJJJJ, createdTime=Tue Oct 05 21:45:10 CST 2021, time=2021-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202427, encodeId=d830120242e02, content=偏重的研究方向：肿瘤 经验分享：写了一篇letter，一个月还在with editor，啥情况啊？有人知道不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0f72309028, createdName=122220a4m01暂无昵称, createdTime=Mon Mar 14 11:29:30 CST 2022, time=2022-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2193317, encodeId=51d0219331ead, content=偏重的研究方向：肿瘤 经验分享：2.27投稿，3.15拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=109a8327611, createdName=ms6000000136446040, createdTime=Fri Mar 15 09:16:46 CST 2024, time=2024-03-15, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2181884, encodeId=af9721818848a, content=偏重的研究方向：肿瘤;肿瘤免疫 经验分享：with editor 2周，进入decsion in process流程，是要凉凉了吗请问?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f7d6548351, createdName=ms6000001244498457, createdTime=Mon Jan 15 21:53:20 CST 2024, time=2024-01-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2189742, encodeId=2fb32189e4282, content=投稿第二天with editor，目前 8天了状态仍然没有变化, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85799188946, createdName=ms1000001401340130, createdTime=Tue Feb 27 20:34:26 CST 2024, time=2024-02-27, status=1, ipAttribution=湖北省)]

2024-03-15 ms6000000136446040 来自上海

偏重的研究方向：肿瘤
经验分享：2.27投稿，3.15拒稿

74 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2225400, encodeId=3ef5222540019, content=偏重的研究方向：肿瘤免疫 经验分享：with editor已经一周了，还是没有变化，这是正常的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65865684646, createdName=ms9000000770995662, createdTime=Thu Sep 12 15:26:21 CST 2024, time=2024-09-12, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2198977, encodeId=638821989e77f, content=做肿瘤免疫。有相关的六七八分的杂志推荐吗，跪求着急毕业, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d0fe8528077, createdName=ms5000000719501821, createdTime=Wed Apr 17 17:11:02 CST 2024, time=2024-04-17, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2222833, encodeId=3b492222833b4, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d1d1660995, createdName=1ddebd51m79(暂无匿称), createdTime=Wed Aug 28 14:24:59 CST 2024, time=2024-08-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2222682, encodeId=8d15222268246, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d1d1660995, createdName=1ddebd51m79(暂无匿称), createdTime=Tue Aug 27 16:09:37 CST 2024, time=2024-08-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2105348, encodeId=7306210534879, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤免疫 经验分享：写了一篇研究性质的letter,1000字左右，投稿后两天直接接收，只能用两个字形容：效率！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520f5425099, createdName=ms3000001872426513, createdTime=Sun Dec 11 11:52:23 CST 2022, time=2022-12-11, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=1057958, encodeId=9aa8105e9580b, content=9-23 submittted 9-26 with editor 9-29 decision in process 10-5 reject 和很多人说的一样，decision in process状态持续的很久。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d21b5560214, createdName=YJJJJJ, createdTime=Tue Oct 05 21:45:10 CST 2021, time=2021-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202427, encodeId=d830120242e02, content=偏重的研究方向：肿瘤 经验分享：写了一篇letter，一个月还在with editor，啥情况啊？有人知道不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0f72309028, createdName=122220a4m01暂无昵称, createdTime=Mon Mar 14 11:29:30 CST 2022, time=2022-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2193317, encodeId=51d0219331ead, content=偏重的研究方向：肿瘤 经验分享：2.27投稿，3.15拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=109a8327611, createdName=ms6000000136446040, createdTime=Fri Mar 15 09:16:46 CST 2024, time=2024-03-15, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2181884, encodeId=af9721818848a, content=偏重的研究方向：肿瘤;肿瘤免疫 经验分享：with editor 2周，进入decsion in process流程，是要凉凉了吗请问?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f7d6548351, createdName=ms6000001244498457, createdTime=Mon Jan 15 21:53:20 CST 2024, time=2024-01-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2189742, encodeId=2fb32189e4282, content=投稿第二天with editor，目前 8天了状态仍然没有变化, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85799188946, createdName=ms1000001401340130, createdTime=Tue Feb 27 20:34:26 CST 2024, time=2024-02-27, status=1, ipAttribution=湖北省)]

2024-01-15 ms6000001244498457 来自北京

偏重的研究方向：肿瘤;肿瘤免疫
经验分享：with editor 2周，进入decsion in process流程，是要凉凉了吗请问?

195 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2225400, encodeId=3ef5222540019, content=偏重的研究方向：肿瘤免疫 经验分享：with editor已经一周了，还是没有变化，这是正常的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65865684646, createdName=ms9000000770995662, createdTime=Thu Sep 12 15:26:21 CST 2024, time=2024-09-12, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2198977, encodeId=638821989e77f, content=做肿瘤免疫。有相关的六七八分的杂志推荐吗，跪求着急毕业, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d0fe8528077, createdName=ms5000000719501821, createdTime=Wed Apr 17 17:11:02 CST 2024, time=2024-04-17, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2222833, encodeId=3b492222833b4, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d1d1660995, createdName=1ddebd51m79(暂无匿称), createdTime=Wed Aug 28 14:24:59 CST 2024, time=2024-08-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2222682, encodeId=8d15222268246, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d1d1660995, createdName=1ddebd51m79(暂无匿称), createdTime=Tue Aug 27 16:09:37 CST 2024, time=2024-08-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2105348, encodeId=7306210534879, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤免疫 经验分享：写了一篇研究性质的letter,1000字左右，投稿后两天直接接收，只能用两个字形容：效率！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520f5425099, createdName=ms3000001872426513, createdTime=Sun Dec 11 11:52:23 CST 2022, time=2022-12-11, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=1057958, encodeId=9aa8105e9580b, content=9-23 submittted 9-26 with editor 9-29 decision in process 10-5 reject 和很多人说的一样，decision in process状态持续的很久。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d21b5560214, createdName=YJJJJJ, createdTime=Tue Oct 05 21:45:10 CST 2021, time=2021-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202427, encodeId=d830120242e02, content=偏重的研究方向：肿瘤 经验分享：写了一篇letter，一个月还在with editor，啥情况啊？有人知道不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0f72309028, createdName=122220a4m01暂无昵称, createdTime=Mon Mar 14 11:29:30 CST 2022, time=2022-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2193317, encodeId=51d0219331ead, content=偏重的研究方向：肿瘤 经验分享：2.27投稿，3.15拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=109a8327611, createdName=ms6000000136446040, createdTime=Fri Mar 15 09:16:46 CST 2024, time=2024-03-15, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2181884, encodeId=af9721818848a, content=偏重的研究方向：肿瘤;肿瘤免疫 经验分享：with editor 2周，进入decsion in process流程，是要凉凉了吗请问?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f7d6548351, createdName=ms6000001244498457, createdTime=Mon Jan 15 21:53:20 CST 2024, time=2024-01-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2189742, encodeId=2fb32189e4282, content=投稿第二天with editor，目前 8天了状态仍然没有变化, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85799188946, createdName=ms1000001401340130, createdTime=Tue Feb 27 20:34:26 CST 2024, time=2024-02-27, status=1, ipAttribution=湖北省)]

2024-02-27 ms1000001401340130 来自湖北省

投稿第二天with editor，目前 8天了状态仍然没有变化

76 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务